The Cooper Companies, Inc. (COO) EV/Sales Ratio: 3.68x
Is The Cooper Companies, Inc.’s EV/Sales ratio high or low?
The Cooper Companies, Inc.'s EV/Sales ratio of 3.68x is 37% below its 5-year average of 5.81x, near the low end of its 5-year range (3.37x–9.14x).
As of Sunday, June 14, 2026. 11.30% below its 12-month average of 4.15x.
COO EV/Sales Ratio Chart
COO Average EV/Sales Ratio Chart
COO Current vs Average EV/Sales Ratio Chart
COO EV/Sales Ratio Metrics
EV/SALES RATIO
3.68x
EV/SALES RATIO AVG TTM
4.15x
EV/SALES RATIO AVG 3Y
5.16x
EV/SALES RATIO AVG 5Y
5.81x
EV/SALES RATIO AVG 10Y
6.14x
EV/SALES RATIO AVG 15Y
5.49x
EV/SALES RATIO AVG 20Y
4.80x
CURRENT VS TTM AVG
-11.30%
CURRENT VS 3Y AVG
-28.71%
CURRENT VS 5Y AVG
-36.63%
CURRENT VS 10Y AVG
-40.04%
CURRENT VS 15Y AVG
-32.98%
CURRENT VS 20Y AVG
-23.34%
COO Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 3.68x | 4.15x | 5.16x | 5.81x |
| Solventum Corporation (SOLV) | $13.66B | 2.22x | 2.19x | 2.26x | 2.26x |
| Align Technology, Inc. (ALGN) | $12.52B | 2.83x | 2.73x | 4.07x | 5.90x |
| Baxter International Inc. (BAX) | $10.77B | 1.63x | 1.72x | 2.17x | 2.64x |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | 0.25x | 0.26x | 0.37x | 0.45x |
| Hologic, Inc. (HOLX) | $16.97B | 4.25x | 4.02x | 4.39x | 4.15x |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 2.99x | 2.79x | 3.02x | 3.79x |
| Tempus AI, Inc. (TEM) | $8.35B | 6.49x | 11.43x | 12.17x | 12.17x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 3.31x | 3.41x | 3.67x | 4.57x |
| Moderna, Inc. (MRNA) | $19.80B | 8.59x | 5.99x | 5.02x | 6.80x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
The Cooper Companies, Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for The Cooper Companies, Inc. (COO)?
- The EV/Sales ratio for COO stock is 3.68x.
- Is The Cooper Companies, Inc.'s EV/Sales ratio high or low?
- The Cooper Companies, Inc.'s EV/Sales ratio of 3.68x is 37% below its 5-year average of 5.81x, near the low end of its 5-year range (3.37x–9.14x).
- What is the TTM average EV/Sales ratio for The Cooper Companies, Inc. (COO)?
- The TTM average EV/Sales ratio for COO stock is 4.15x.
- What is the 3Y average EV/Sales ratio for The Cooper Companies, Inc. (COO)?
- The 3Y average EV/Sales ratio for COO stock is 5.16x.
- What is the 5Y average EV/Sales ratio for The Cooper Companies, Inc. (COO)?
- The 5Y average EV/Sales ratio for COO stock is 5.81x.
- What is the 10Y average EV/Sales ratio for The Cooper Companies, Inc. (COO)?
- The 10Y average EV/Sales ratio for COO stock is 6.14x.
- What is the 15Y average EV/Sales ratio for The Cooper Companies, Inc. (COO)?
- The 15Y average EV/Sales ratio for COO stock is 5.49x.
- What is the 20Y average EV/Sales ratio for The Cooper Companies, Inc. (COO)?
- The 20Y average EV/Sales ratio for COO stock is 4.80x.
The Cooper Companies, Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-12 | 3.68x |
| 2026-06-11 | 3.66x |
| 2026-06-10 | 3.67x |
| 2026-06-09 | 3.71x |
| 2026-06-08 | 3.63x |
| 2026-06-05 | 3.65x |
| 2026-06-04 | 3.51x |
| 2026-06-03 | 3.43x |
| 2026-06-02 | 3.39x |
| 2026-06-01 | 3.42x |
| 2026-05-29 | 3.47x |
| 2026-05-28 | 3.46x |
| 2026-05-27 | 3.45x |
| 2026-05-26 | 3.51x |
| 2026-05-22 | 3.54x |
| 2026-05-21 | 3.55x |
| 2026-05-20 | 3.50x |
| 2026-05-19 | 3.48x |
| 2026-05-18 | 3.46x |
| 2026-05-15 | 3.40x |
| 2026-05-14 | 3.43x |
| 2026-05-13 | 3.39x |
| 2026-05-12 | 3.41x |
| 2026-05-11 | 3.37x |
| 2026-05-08 | 3.41x |
| 2026-05-07 | 3.47x |
| 2026-05-06 | 3.47x |
| 2026-05-05 | 3.47x |
| 2026-05-04 | 3.49x |
| 2026-05-01 | 3.53x |
| 2026-04-30 | 3.55x |
| 2026-04-29 | 3.48x |
| 2026-04-28 | 3.56x |
| 2026-04-27 | 3.62x |
| 2026-04-24 | 3.62x |
| 2026-04-23 | 3.65x |
| 2026-04-22 | 3.74x |
| 2026-04-21 | 3.76x |
| 2026-04-20 | 3.86x |
| 2026-04-17 | 3.89x |
| 2026-04-16 | 3.86x |
| 2026-04-15 | 3.90x |
| 2026-04-14 | 3.96x |
| 2026-04-13 | 3.97x |
| 2026-04-10 | 3.95x |
| 2026-04-09 | 3.96x |
| 2026-04-08 | 3.97x |
| 2026-04-07 | 3.87x |
| 2026-04-06 | 3.90x |
| 2026-04-02 | 3.90x |
| 2026-04-01 | 3.96x |
| 2026-03-31 | 3.96x |
| 2026-03-30 | 3.86x |
| 2026-03-27 | 3.88x |
| 2026-03-26 | 3.96x |
| 2026-03-25 | 3.96x |
| 2026-03-24 | 3.91x |
| 2026-03-23 | 3.90x |
| 2026-03-20 | 3.89x |
| 2026-03-19 | 3.92x |
| 2026-03-18 | 3.94x |
| 2026-03-17 | 3.99x |
| 2026-03-16 | 3.94x |
| 2026-03-13 | 3.88x |
| 2026-03-12 | 3.96x |
| 2026-03-11 | 4.07x |
| 2026-03-10 | 4.10x |
| 2026-03-09 | 4.16x |
| 2026-03-06 | 4.20x |
| 2026-03-05 | 4.54x |
| 2026-03-04 | 4.62x |
| 2026-03-03 | 4.69x |
| 2026-03-02 | 4.72x |
| 2026-02-27 | 4.70x |
| 2026-02-26 | 4.72x |
| 2026-02-25 | 4.69x |
| 2026-02-24 | 4.70x |
| 2026-02-23 | 4.67x |
| 2026-02-20 | 4.72x |
| 2026-02-19 | 4.70x |
| 2026-02-18 | 4.69x |
| 2026-02-17 | 4.62x |
| 2026-02-13 | 4.67x |
| 2026-02-12 | 4.61x |
| 2026-02-11 | 4.67x |
| 2026-02-10 | 4.60x |
| 2026-02-09 | 4.60x |
| 2026-02-06 | 4.63x |
| 2026-02-05 | 4.53x |
| 2026-02-04 | 4.57x |
| 2026-02-03 | 4.49x |
| 2026-02-02 | 4.56x |
| 2026-01-30 | 4.59x |
| 2026-01-29 | 4.54x |
| 2026-01-28 | 4.55x |
| 2026-01-27 | 4.56x |
| 2026-01-26 | 4.57x |
| 2026-01-23 | 4.59x |
| 2026-01-22 | 4.66x |
| 2026-01-21 | 4.65x |
| 2026-01-20 | 4.56x |
| 2026-01-16 | 4.64x |
| 2026-01-15 | 4.64x |
| 2026-01-14 | 4.61x |
| 2026-01-13 | 4.61x |
| 2026-01-12 | 4.68x |
| 2026-01-09 | 4.69x |
| 2026-01-08 | 4.68x |
| 2026-01-07 | 4.71x |
| 2026-01-06 | 4.73x |
| 2026-01-05 | 4.66x |
| 2026-01-02 | 4.58x |
| 2025-12-31 | 4.62x |
| 2025-12-30 | 4.65x |
| 2025-12-29 | 4.63x |
| 2025-12-26 | 4.65x |
| 2025-12-24 | 4.65x |
| 2025-12-23 | 4.67x |
| 2025-12-22 | 4.71x |
| 2025-12-19 | 4.66x |
| 2025-12-18 | 4.64x |
| 2025-12-17 | 4.65x |
| 2025-12-16 | 4.58x |
| 2025-12-15 | 4.60x |
| 2025-12-12 | 4.63x |
| 2025-12-11 | 4.63x |
| 2025-12-10 | 4.56x |
| 2025-12-09 | 4.45x |
| 2025-12-08 | 4.43x |
| 2025-12-05 | 4.59x |
| 2025-12-04 | 4.40x |
| 2025-12-03 | 4.35x |
| 2025-12-02 | 4.34x |
| 2025-12-01 | 4.42x |
| 2025-11-28 | 4.45x |
| 2025-11-26 | 4.45x |
| 2025-11-25 | 4.46x |
| 2025-11-24 | 4.35x |
| 2025-11-21 | 4.32x |
| 2025-11-20 | 4.11x |
| 2025-11-19 | 4.16x |
| 2025-11-18 | 4.16x |
| 2025-11-17 | 4.12x |
| 2025-11-14 | 4.16x |
| 2025-11-13 | 4.14x |
| 2025-11-12 | 4.18x |
| 2025-11-11 | 4.14x |
| 2025-11-10 | 4.09x |
| 2025-11-07 | 4.06x |
| 2025-11-06 | 4.00x |
| 2025-11-05 | 4.00x |
| 2025-11-04 | 4.01x |
| 2025-11-03 | 4.04x |
| 2025-10-31 | 4.05x |
| 2025-10-30 | 4.06x |
| 2025-10-29 | 4.03x |
| 2025-10-28 | 4.14x |
| 2025-10-27 | 4.19x |
| 2025-10-24 | 4.23x |
| 2025-10-23 | 4.28x |
| 2025-10-22 | 4.27x |
| 2025-10-21 | 4.30x |
| 2025-10-20 | 4.30x |
| 2025-10-17 | 4.15x |
| 2025-10-16 | 4.13x |
| 2025-10-15 | 3.99x |
| 2025-10-14 | 4.11x |
| 2025-10-13 | 4.02x |
| 2025-10-10 | 3.97x |
| 2025-10-09 | 4.04x |
| 2025-10-08 | 4.07x |
| 2025-10-07 | 4.00x |
| 2025-10-06 | 4.06x |
| 2025-10-03 | 4.08x |
| 2025-10-02 | 4.01x |
| 2025-10-01 | 3.96x |
| 2025-09-30 | 3.98x |
| 2025-09-29 | 3.94x |
| 2025-09-26 | 3.93x |
| 2025-09-25 | 3.90x |
| 2025-09-24 | 3.97x |
| 2025-09-23 | 3.93x |
| 2025-09-22 | 3.95x |
| 2025-09-19 | 3.96x |
| 2025-09-18 | 3.91x |
| 2025-09-17 | 3.77x |
| 2025-09-16 | 3.81x |
| 2025-09-15 | 3.83x |
| 2025-09-12 | 3.89x |
| 2025-09-11 | 3.98x |
| 2025-09-10 | 3.94x |
| 2025-09-09 | 3.97x |
| 2025-09-08 | 3.99x |
| 2025-09-05 | 3.96x |
| 2025-09-04 | 3.95x |
| 2025-09-03 | 3.91x |
| 2025-09-02 | 3.82x |
| 2025-08-29 | 3.92x |
| 2025-08-28 | 3.78x |
| 2025-08-27 | 4.35x |
| 2025-08-26 | 4.33x |
| 2025-08-25 | 4.32x |
| 2025-08-22 | 4.40x |
| 2025-08-21 | 4.29x |
| 2025-08-20 | 4.32x |
| 2025-08-19 | 4.34x |
| 2025-08-18 | 4.32x |
| 2025-08-15 | 4.31x |
| 2025-08-14 | 4.31x |
| 2025-08-13 | 4.36x |
| 2025-08-12 | 4.28x |
| 2025-08-11 | 4.19x |
| 2025-08-08 | 4.16x |
| 2025-08-07 | 4.10x |
| 2025-08-06 | 4.05x |
| 2025-08-05 | 4.12x |
| 2025-08-04 | 4.21x |
| 2025-08-01 | 4.19x |
| 2025-07-31 | 4.18x |
| 2025-07-30 | 4.26x |
| 2025-07-29 | 4.33x |
| 2025-07-28 | 4.29x |
| 2025-07-25 | 4.37x |
| 2025-07-24 | 4.33x |
| 2025-07-23 | 4.31x |
| 2025-07-22 | 4.29x |
| 2025-07-21 | 4.21x |
| 2025-07-18 | 4.27x |
| 2025-07-17 | 4.31x |
| 2025-07-16 | 4.28x |
| 2025-07-15 | 4.25x |
| 2025-07-14 | 4.32x |
| 2025-07-11 | 4.38x |
| 2025-07-10 | 4.48x |
| 2025-07-09 | 4.39x |
| 2025-07-08 | 4.36x |
| 2025-07-07 | 4.31x |
| 2025-07-03 | 4.31x |
| 2025-07-02 | 4.29x |
| 2025-07-01 | 4.28x |
| 2025-06-30 | 4.20x |
| 2025-06-27 | 4.20x |
| 2025-06-26 | 4.13x |
| 2025-06-25 | 4.12x |
| 2025-06-24 | 4.19x |
| 2025-06-23 | 4.12x |
| 2025-06-20 | 4.12x |
| 2025-06-18 | 4.13x |
| 2025-06-17 | 4.08x |
| 2025-06-16 | 4.13x |
| 2025-06-13 | 4.13x |
| 2025-06-12 | 4.19x |
| 2025-06-11 | 4.21x |
| 2025-06-10 | 4.28x |
| 2025-06-09 | 4.24x |
| 2025-06-06 | 4.26x |
| 2025-06-05 | 4.20x |
| 2025-06-04 | 4.01x |
| 2025-06-03 | 3.99x |
| 2025-06-02 | 3.99x |
Showing the most recent 260 of 5,033 data points. The chart above shows the full history.
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White